Log in

NRX Nurexone Biologic Inc TSXV · Canada

Nurexone Biologic (NRX) news

Nurexone Biologic Inc is a public biotech or pharmaceutical company listed on TSXV under the ticker NRX, recorded under Canada. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Nurexone Biologic news

We have not published a story on Nurexone Biologic yet. When there is news, it will appear here.

Questions about Nurexone Biologic

What is the ticker symbol of Nurexone Biologic?

Nurexone Biologic Inc trades under the ticker NRX on TSXV.

Where is Nurexone Biologic listed?

Nurexone Biologic Inc is listed on TSXV. Our directory also records these other listings: GETTEX:J90; LS:A3DNSU; LSX:A3DNSU; OTC:NRXBF.

Which country or territory is Nurexone Biologic listed under?

Our directory records Nurexone Biologic Inc under Canada.

What does Nurexone Biologic do?

Our directory classifies Nurexone Biologic Inc as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Nurexone Biologic?

The ISIN recorded for Nurexone Biologic Inc is CA67059R1091.

Does aibio.space cover Nurexone Biologic?

aibio.space lists Nurexone Biologic Inc among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Nurexone Biologic?

Companies in our directory listed in the same country and business area as Nurexone Biologic: COSCIENS Biopharma, EGF Theramed Health, Medicure, Mindbio Therapeutics, Marvel Biosciences, PreveCeutical Medical.

Investor discussion: Nurexone Biologic

Members talk about Nurexone Biologic (NRX). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open TSXV:NRX on TradingView.

Listing details

Nurexone Biologic Inc is a public biotech or pharmaceutical company listed on TSXV under the ticker NRX, recorded under Canada. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Nurexone Biologic Inc
Ticker
NRX
Listing
TSXV
Country or territory
Canada
Business scope
Pharmaceuticals: Major
ISIN
CA67059R1091
Other listed symbols
GETTEX:J90; LS:A3DNSU; LSX:A3DNSU; OTC:NRXBF
Last quote in directory
2026-10-21
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.